OXUR Share Price Performance
€0.003
-0.04 (-93.24%)
Price €0.003
Share Pricen/a
Oxurion NV Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
OXUR Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Oxurion NV Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Sep 30, 2026
- -0.042
- 100.00%
- -671.71%
- -89.0%
About OXUR
- Founded
- 1991
- Employees
- 26
- CEO
- WebsiteView website
Oxurion NV, a biopharmaceutical company, develops medicines for vascular retinal disorder in Belgium. The company is developing ophthalmic treatments to preserve vision for patients geographic atrophy and wet age-related macular degeneration. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium.